FDA: Authorizations of Emergency Use of Certain Drug and Biological Products During the COVID-19 Pandemic; Availability
Source
Federal Register
Link
Date
Feb 19, 2021
Summary
The Food and Drug Administration (FDA) announces five Emergency Use Authorizations for drugs and biological products for use during the COVID-19 pandemic. These authorizations are effective on their date of issuance.
Tagged as
Infectious diseases · Pharmacy and prescription drugs · Policy